LENZ Therapeutics

📍 San Diego, United States👥 24 employees💰 Last funded 2020
Pharmaceutical Manufacturing🌐 LENZ-Tx.com
Website LinkedIn
LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia. Presbyopia impacts almost two billion people globally and more than 120 million people in the US. LENZ Therapeutics is headquartered in San Diego, California, and is backed by multiple blue-chip venture capital investors.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in LENZ Therapeutics?
LENZ Therapeutics has 1 investors on record on gritt.io.
When did LENZ Therapeutics last raise funding?
The most recent investment in LENZ Therapeutics recorded on gritt.io was in 2020.
What industry is LENZ Therapeutics in?
LENZ Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is LENZ Therapeutics based?
LENZ Therapeutics is headquartered in San Diego, United States.